Managing Director of Aristo Pharma Sp. z o.o. (former AXXON Sp. z o.o.) since July 2009. A graduate of the Faculty of Pharmacy of the Warsaw Medical Academy. For 24 years associated with the pharmaceutical industry. At Actavis he was the Regional Director and was responsible for such countries as Poland, Hungary, the Czech Republic, Serbia, Slovakia and Slovenia. Previously, for several years he held the position of the national director at Sindan. He gained his first professional experience as a product manager, business unit manager and business development manager in such companies as Schwarz Pharma, Hoechst Marion Roussel (now Sanofi Aventis).
SALES AND MARKETING
At Aristo Pharma Sp. z o.o. (former AXXON Sp. z o.o.), he has been the sales director since 2010. A graduate of the Medical Faculty of the Medical Academy in Łódź. In 1995 he completed a specialization in orthopedics and traumatology. He gained knowledge in the field of management, among others in the MBA at the Leon Koźmiński University in Warsaw (1996). In 1995, he began working in the pharmaceutical industry at the Eli Lilly international company. He continued gaining his experience in pharmacy in Biovena Pharma (2000-2005), Actavis (2005-2010) and Aristo Pharma Sp. z o.o. (former AXXON Sp. z o.o.) (from 2010).
DEVELOPMENT AND REGISTRATION
OF MEDICINAL PRODUCTS DIRECTOR
A graduate of the Faculty of Chemistry of the University of Gdańsk and postgraduate studies at the College of Trade and Finance in Warsaw, certified Regulatory Affairs Manager with over 14 years of experience in the pharmaceutical industry and Regulatory Affairs. She gained her professional experience, among others in Biovena Pharma and Actavis Polska. She did many trainings and specialization workshops. She successfully carried out and supervised nearly two hundred registration procedures. She managed the "life cycle" of over two hundred generic and original medicinal products. Has been working with Aristo Pharma Sp. z o.o. (former AXXON Sp. z o.o.) since January 2014. In September 2015, she took the position of director for the development and registration of medicinal products. In the company she is responsible for the Research and Development Department, Registration Department, Pharmacovigilance and Quality Control. She has been a Member of the Management Board since 2015.